stroke15 a2ad2
Name
a2a2
Label
Angiotensin Type 2 Antagonists (SHHS2)
Description

Participant taking ANGIOTENSIN TYPE 2 ANTAGONISTS within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
A2A2 hypertension
Angiotensin Type 2 Antagonists (SHHS2) vs SHHS Visit Number
Visit 1 Visit 2 CVD Outcomes
Total - 4,080 -
No - 3,444 -
Yes - 176 -
Unknown - 460 -
Angiotensin Type 2 Antagonists (SHHS2) vs Age at SHHS1
Visit 2
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 184 707 1,321 1,200 624 44 4,080
No 174 639 1,079 999 514 39 3,444
Yes 2 8 69 57 39 1 176
Unknown 8 60 173 144 71 4 460
Angiotensin Type 2 Antagonists (SHHS2) vs Gender
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,587 1,857 3,444
Yes 74 102 176
Unknown 200 260 460
Angiotensin Type 2 Antagonists (SHHS2) vs Race
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 3,008 232 204 3,444
Yes 154 10 12 176
Unknown 425 14 21 460